Even it is rare metastasis of BCC in the genital area has been reported (36)
Motus reported about a 10.4 percent average weight loss in human clinical trials over six months which is exceptional for a supplement and positions it strongly among oral approaches
Symptoms like fatigue (R53.83) or dizziness (R42) may be coded separately only when documented as standalone clinical concerns that arent fully captured by the anemia diagnosis
That broader receptor profile is why MT-II is studied across pigmentation, appetite, and sexual-function pathways, while MT-I research focuses narrowly on cutaneous melanogenesis and photoprotection endpoints
This is the first pharmacological agent to show prognostic benefit in this population, offering therapeutic potential beyond symptomatic control
According to Genevieve Parker, a research assistant in Benjamin Bikmans cell biology lab at BYU, one of those concerns is muscle loss